NCT07066839View on ClinicalTrials.gov

Chrysin Bioavailability and Safety

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 5, 2024

Primary Completion Date

February 21, 2025

Study Completion Date

April 2, 2025

Conditions
Bioavailability and PharmacokineticsSafety After Oral Intake
Interventions
DIETARY_SUPPLEMENT

LipoMicel Chrysin

A maximum single oral dose of 1000 mg chrysin

DIETARY_SUPPLEMENT

Non-Micellar Chrysin

A maximum single oral dose of 1000 mg chrysin

DIETARY_SUPPLEMENT

Standard/Unformulated Chrysin

A maximum single oral dose of 1000 mg chrysin

Trial Locations (1)

Unknown

ISURA, Burnaby

All Listed Sponsors
lead

Isura

OTHER

NCT07066839 - Chrysin Bioavailability and Safety | Biotech Hunter | Biotech Hunter